España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BioXcel Therapeutics
BTAI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.3410
0.03
8.12%
At close: -
$0.3419
0.00090
0.26%
After Hours: Dec 20, 7:10 PM EDT
Get Report
Comment
BioXcel Therapeutics (BTAI) Forecast
News
Earnings
BioXcel Therapeutics (BTAI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for BioXcel Therapeutics (NASDAQ:BTAI) Stock
BioXcel Therapeutics Stock (NASDAQ: BTAI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 22, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
BioXcel Therapeutics shares are trading lower...
Benzinga Newsdesk
BioXcel Therapeutics Prices $7M Public Offeri...
Benzinga Newsdesk
Thursday, November 21, 2024
BioXcel Therapeutics Commences Public Offerin...
Benzinga Newsdesk
Thursday, November 14, 2024
BioXcel Therapeutics shares are trading lower...
Benzinga Newsdesk
BioXcel Therapeutics Q3 2024 GAAP EPS $(0.32)...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
What's Next: BioXcel Therapeutics's Earnings Preview
Benzinga Insights
Tuesday, November 12, 2024
BioXcel Therapeutics Announced The Achievemen...
Benzinga Newsdesk
Monday, October 21, 2024
HC Wainwright & Co. Maintains Buy on BioXcel ...
Benzinga Newsdesk
Tuesday, October 15, 2024
BioXcel Therapeutics Reports Department Of De...
Benzinga Newsdesk
Thursday, September 19, 2024
Bioxcel Therapeutics Will Reduce Its Workforc...
Benzinga Newsdesk
Bioxcel Therapeutics Announced Its Clinical P...
Benzinga Newsdesk
Friday, September 06, 2024
HC Wainwright & Co. Reiterates Buy on BioXcel...
Benzinga Newsdesk
Thursday, September 05, 2024
BioXcel Therapeutics Initiated Patient Enroll...
Benzinga Newsdesk
Friday, August 30, 2024
Canaccord Genuity Maintains Buy on BioXcel Th...
Benzinga Newsdesk
Friday, August 09, 2024
UBS Maintains Neutral on BioXcel Therapeutics...
Benzinga Newsdesk
Thursday, August 08, 2024
HC Wainwright & Co. Maintains Buy on BioXcel ...
Benzinga Newsdesk
Tuesday, August 06, 2024
BioXcel Therapeutics shares are trading highe...
Benzinga Newsdesk
BioXcel Therapeutics Q2 2024 GAAP EPS $(0.21)...
Benzinga Newsdesk
Tuesday, July 16, 2024
BioXcel Therapeutics Announced Preliminary Sa...
Benzinga Newsdesk
Thursday, June 27, 2024
Canaccord Genuity Maintains Buy on BioXcel Th...
Benzinga Newsdesk
Tuesday, June 25, 2024
BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study
Vandana Singh
BioXcel Therapeutics Reports Topline Results ...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Reiterates Buy on BioXcel...
Benzinga Newsdesk
Thursday, May 09, 2024
BioXcel Therapeutics shares are trading highe...
Benzinga Newsdesk
BioXcel Therapeutics Q1 2024 GAAP EPS $(0.87)...
Benzinga Newsdesk
Wednesday, April 24, 2024
BioXcel Therapeutics Announces Late-Breaking ...
Benzinga Newsdesk
Tuesday, April 23, 2024
HC Wainwright & Co. Reiterates Buy on BioXcel...
Benzinga Newsdesk
Monday, April 22, 2024
BioXcel Therapeutics Reveals Plan For Evaluat...
Benzinga Newsdesk
Wednesday, April 10, 2024
BioXcel Therapeutics Announced Details Regard...
Benzinga Newsdesk
Monday, March 25, 2024
BioXcel Therapeutics shares are trading lower...
Benzinga Newsdesk
BioXcel Therapeutics Announces $25M Registere...
Benzinga Newsdesk
Monday, March 18, 2024
HC Wainwright & Co. Reiterates Buy on BioXcel...
Benzinga Newsdesk
Friday, March 15, 2024
BioXcel Therapeutics Reported That The Europe...
Benzinga Newsdesk
Thursday, March 14, 2024
Canaccord Genuity Maintains Buy on BioXcel Th...
Benzinga Newsdesk
Wednesday, March 13, 2024
B of A Securities Maintains Buy on BioXcel Th...
Benzinga Newsdesk
Tuesday, March 12, 2024
BioXcel Therapeutics shares are trading highe...
Benzinga Newsdesk
BioXcel Therapeutics' Cash And Cash Equivalen...
Benzinga Newsdesk
BioXcel Therapeutics Q4 GAAP EPS $(0.76) Beat...
Benzinga Newsdesk
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
BioXcel Therapeutics's Earnings Outlook
Benzinga Insights
Tuesday, February 27, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, February 14, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, February 13, 2024
Why BioXcel Therapeutics Shares Are Rising Tuesday
Nabaparna Bhattacharya
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
BioXcel Therapeutics Terminates $60M Proposed...
Benzinga Newsdesk
Monday, February 12, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
BioXcel Therapeutics Secures FDA Fast Track D...
Benzinga Newsdesk
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch